Apotex Holdings Inc. completes sale of Accucaps Industries to Catalent Pharma Solutions

On February 16, 2017, Catalent Pharma Solutions Ltd. announced the completion of its purchase of all of the shares of Accucaps Industries Ltd. from Apotex Holdings Inc. for an undisclosed price. 

Accucaps is a developer and manufacturer of over-the-counter pharmaceutical softgels and operates two state-of-the art softgel development, manufacturing and packaging facilities in Windsor and Strathroy, Ont. The acquisition complements and enhances Catalent’s global network of 11 softgel technology facilities. 

Apotex Holdings Inc. was represented by Torkin Manes LLP, with a team led by Jeffrey Cohen and including Sammy Redlick and Adrian Myers.

To read the complete details in Lexpert Magazine, click here.